ServareGMP

ServareGMP is a non-profit public benefit corporation founded in 2020 with a mission to address the unmet medical needs of underserved populations. The company focuses on developing and manufacturing low-cost biologic medicines targeting infectious and neglected diseases affecting vulnerable demographics. ServareGMP aims to achieve this through three primary pathways: producing very low-cost medicines, collaborating with like-minded organizations to address the needs of underserved populations, and establishing biomanufacturing operations in collaboration with colleagues in low- and middle-income countries (LMICs). Operating in the Biotechnology industry, ServareGMP's objective is to use their capabilities to meet the needs of the underserved, the neglected, and the vulnerable. With a headquarter in the United States, the company has not disclosed its last investment details or participating investors. The company's slogan encapsulates its core objective: "ServareGMP’s objective is to use its capabilities to meet the needs of the underserved, the neglected and the vulnerable."